Methylation sites of human papillomavirus 16 as potential biomarkers for cervical cancer progression
ObjectiveTo investigate the methylation levels at 13 specific sites of the human papillomavirus 16 (HPV16) L1 gene as potential biomarkers for the diagnosis of cervical cancer.MethodsSamples were collected from the gynecological outpatient and inpatient departments of the Xinjiang Uygur Autonomous R...
Saved in:
Main Authors: | Sha Ji, Nannan Ji |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1481621/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Human papillomavirus type 16 E7 promotes cell viability and migration in cervical cancer by regulating the miR-23a/HOXC8 axis
by: Yahang Chen, et al.
Published: (2024-12-01) -
Research progress of DNA methylation in the screening of cervical cancer and precancerous lesions
by: Yunge Wang, et al.
Published: (2025-01-01) -
The impact of HPV/HIV co-infection on immunosuppression, HPV genotype, and cervical cancer biomarkers
by: Terkimbi Dominic Swase, et al.
Published: (2025-02-01) -
The Relationship Between Cervicovaginal Infection, Human Papillomavirus Infection and Cervical Intraepithelial Neoplasia in Romanian Women
by: Anca Daniela Brăila, et al.
Published: (2025-01-01) -
Development and evaluation of a novel E7 multi-epitopic vaccine for human papillomavirus type 16: design, expression, purification, and immunological characterization
by: Bahareh Bahmani, et al.
Published: (2025-02-01)